These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7738574

  • 1. Successful treatment of intractable tardive dyskinesia with botulinum toxin.
    Yasufuku-Takano J, Sakurai M, Kanazawa I, Nagaoka M.
    J Neurol Neurosurg Psychiatry; 1995 Apr; 58(4):511-2. PubMed ID: 7738574
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Botulinum toxin in treatment of tardive dyskinetic syndrome.
    Truong DD, Hermanowicz N, Rontal M.
    J Clin Psychopharmacol; 1990 Dec; 10(6):438-9. PubMed ID: 2286715
    [No Abstract] [Full Text] [Related]

  • 6. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK, Jankovic J.
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN, Hovestadt A.
    Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083
    [Abstract] [Full Text] [Related]

  • 8. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D, Jankovic J.
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L, Salazar Z, Micheli F.
    Clin Neuropharmacol; 2009 May; 32(3):165-6. PubMed ID: 19483486
    [Abstract] [Full Text] [Related]

  • 10. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM.
    J Neuropsychiatry Clin Neurosci; 1994 May; 6(1):50-3. PubMed ID: 8148637
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
    Nijmeijer SW, Koelman JH, Kamphuis DJ, Tijssen MA.
    Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
    Hara K, Matsuda A, Kitsukawa Y, Tanaka K, Nishizawa M, Tagawa A.
    Mov Disord; 2007 Jul 15; 22(9):1363-4. PubMed ID: 17486596
    [No Abstract] [Full Text] [Related]

  • 16. Bereitschaftspotential in tardive dyskinesia.
    Adler LE, Pecevich M, Nagamoto H.
    Mov Disord; 1989 Jul 15; 4(2):105-12. PubMed ID: 2733704
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clonazepam in the treatment of tardive dyskinesia].
    Alecu C, Mărcuţiu V, Pruskauer-Apostol B, Voiculescu V.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1984 Jul 15; 29(4):285-9. PubMed ID: 6241738
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T.
    Expert Opin Investig Drugs; 2015 Jun 15; 24(6):737-42. PubMed ID: 25809133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.